Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cardiomyopathies × Carvedilol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Cardiotoxicity 3 Heart Failure 2 Ventricular Dysfunction 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Cardiomyopathies 1 Breast Neoplasms, Male 1

Interventions

Vascular Stiffness 1 Valsartan 1 Pulse Wave Analysis 1 Observation 1 Exercise 1 Electrocardiography 1 Echocardiography 1 Carvedilol 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04023110 2025-10-09

CCTGuide Pilot

Abramson Cancer Center at Penn Medicine

Phase 1 Completed

68 enrolled 20 charts

Breast Neoplasms, Heart Failure, Cardiomyopathies, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡